The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research
Open Access
- 21 June 2025
- journal article
- research article
- Published by Springer Nature in npj Breast Cancer
- Vol. 11 (1) , 1-5
Abstract
Involving patient advocates as partners in cancer research improves research and provides favorable experiences for both the researcher and the advocate. Previous work demonstrates challenges to establishing relationships between researchers and advocates, including uncertainty about why the relationships are necessary, how to establish them, what to say, and how they should be structured. To overcome these challenges, we established the Metastatic Breast Cancer Research Conference (MBCRC) Advocate Researcher Program (MARP) at the MBCRC in 2023. We outline the approach to the program to serve as a model for others interested in performing similar activities and report findings from surveys to establish evidence about the value of these relationships. The program connected 21 pairs of researchers and advocates, and participants responded to surveys about their experience, largely describing positive outcomes. Our hope is that a program like this could be used at any cancer conference in the future as we continue to encourage advocates and researchers to work together.Keywords
Funding Information
- American Association of University Women
This publication has 5 references indexed in Scilit:
- Patient Advocates and Researchers as Partners in Cancer Research: A Winning CombinationAmerican Society of Clinical Oncology Educational Book, 2023
- Adopting recommendations for implementing patient involvement in cancer research: a funder’s approachResearch Involvement and Engagement, 2023
- Improving the odds together: a framework for breast cancer research scientists to include patient advocates in their researchnpj Breast Cancer, 2022
- Patient Engagement in Cancer Research from the Patient’s PerspectiveFuture Oncology, 2021
- Transforming research: engaging patient advocates at all stages of cancer researchAnnals of Translational Medicine, 2018